Table 3.

Incidence of serious adverse events requiring hospitalization (safety population)

Adverse events	No. of subjects, n (%)		p -value*
	KD-287 (n = 102)	JEV-GCC (n = 102)
Total	17 (16.67)	23 (22.55)	0.373
Febrile seizure	1 (0.98)	-	1.000
Otitis Media	1 (0.98)	1 (0.98)	1.000
Pharyngitis	2 (1.96)	1 (0.98)	1.000
Laryngitis	1 (0.98)	-	1.000
Bronchitis	4 (3.92)	4 (3.92)	1.000
Pneumonia	5 (4.90)	13 (12.75)	0.127
Influenza	-	1 (0.98)	1.000
Gastroenteritis	1 (0.98)	3 (2.94)	0.369
Others†	2 (1.96)	-	0.498

*The p-value was calculated using the chi-square or Fisher’s exact test.

^†Others included a case of vaccine overdose and a case of accessory skin tag.